Category Archives: LABD-24-16

The Seven-Year ‘Wedge’

December 15, 2024 By in $SPSIBI, 2007 - 2008, Biotech, Bonds, DHI, Interest Rates, LABD, LABD-24-16, SPBIO, TLT, XBI Tags: , , , ,

Massive Top Formation

D.R. Horton, (DHI) is the largest cap in the Residential Construction Sector (www.tc2000.com).

During the last blow-up (2005 – 2008), DHI, declined top-to-bottom over -91%.

Will it be different this time?

One thing that’s likely, the next implosion could be hit with widespread market and broker outages (not advice, not a recommendation).

The last (notable) time was here.

As far as known, feel free to comment to the contrary, this site’s the only one that incorporates outage potential (and reality) into its trading plan.

Case in point is this link.

The firm’s trade records show, on that Monday, the account was short: LABD-24-16.

The broker outage and panic helped the position. The trade was closed on August 8th, with a profit of 11.15%.

Enough said, let’s move on.

D.R. Horton DHI, Monthly

There it is, seven-years in the making.

We’re at the lower wedge boundary now.

Recently, bonds (TLT) had a minor move higher (rates lower), lasting two-weeks.

However, last week, TLT reversed down and eclipsed the previous two-weeks of gains.

Rates are now moving higher … again.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

A Tale of Two Scenarios

August 8, 2024 By in $SPSIBI, Biotech, LABD, LABD-24-16, SPBIO, XBI 2 Comments

One Up … One Down

No sooner had price action appeared to confirm a breakaway gap (link here), than today, it begins to threaten closing that gap.

With that said, we’ll look at two most likely scenarios for the coming session(s).

Biotech XBI, Daily

If XBI, manages to close the gap, it puts price action into an up-thrust condition as well.

A lower print keeps the breakaway gap intact and hints at much lower levels to come (not advice, not a recommendation).

Housekeeping

Short trade LABD-24-16, has been closed: Total Profit just over 11%.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Breakaway Gap … Biotech

August 7, 2024 By in $SPSIBI, Biotech, Bonds, Interest Rates, LABD, LABD-24-16, SPBIO, TLT, XBI 2 Comments

‘Today Was The Day … ‘

If there was a day to attempt a close of the (August 2nd) gap in biotech (XBI), today was that day.

With the higher open, supposedly from an interest rate policy reversal in Japan, link here and here, there appeared to be plenty of upside momentum for higher prices.

It didn’t happen

Instead, XBI posted a new daily low, painting that gap as a downside breakaway (not advice, not a recommendation).

As noted in other updates, failed moves are the most telling, getting focused attention from ‘The Street’.

Biotech XBI, Daily

The breakaway is noted.

In addition, trendlines have been updated.

The market could somehow recover and close the gap.

However, with the poor bond auction, pointing to no rate cut or even a rate increase, probabilities suggest more downside for XBI (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Brokerages Blow Up

August 5, 2024 By in $SPSIBI, Biotech, Dollar, Dr. Elder, LABD, LABD-24-16, SPBIO, UUP, XBI 1 Comment

Positioned Ahead of Time

Developing a trading plan that accounts for broker outages, blow-ups, and platform lockups, was presented on this site, as early as December of 2020.

Back then, we had this:

“Built into that [system] approach is recognition there will be market outages, trading halts, communication interruptions and natural disasters.“

“The one thing that may separate this site from others, these (potential) events are taken into account.“

Fast forward to now.

Those events are not ‘potential’ anymore, but a reality.

Note: Before leaving that post, from December 2020, let’s not forget, the dollar reversal (and rally) discussed, is still going, nearly four years later!

That’s what’s meant by ‘a strategic, engineering perspective’ (see About).

Moving on to the topic at hand.

The last update showed potential trendlines in biotech, XBI.

As a result of today’s action, we’re revisiting the post with new information.

Biotech XBI, Weekly

As Dr. Elder said years ago, ‘trendlines are not made of glass’. Trendlines are more like a wire fence; the market can attempt a breakout that may ultimately get negated.

With the weekly XBI, that may be the case.

We’re about one hour before the close, only one day into the trading week; it’s pre-mature to say XBI, will finish the week (or even the day) inside the trendline shown above.

However, if we do end the week lower, it may be a serious bellwether; XBI could be in deep kimchi (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Stop … Drop … Trend

August 4, 2024 By in $SPSIBI, Biotech, David Weis, LABD, LABD-24-16, SPBIO, Wyckoff, XBI 3 Comments

Early Signals

It’s never too soon to look for a trend.

The daily chart of biotech XBI, may be showing us early signals of a trend as well as trading channel.

Back in the day, when being mentored by David Weis, he would typically start the session by putting up a chart on his computer (with me logged in remotely) and then ask:

“What do you see?”

More importantly, he did not ask, what I ‘thought’ or what the Fed was doing, or any other mainstream form of distraction. No, it was always “What do you see?”

So, we’ll do the same.

Biotech XBI, Daily

We’re moving in close with the (un-marked) 3-month, daily; what do you see?

Two things should be noticed almost instantly.

Frist: Heavy volume at the last session this past Friday.

Second: Price action (the close) is hanging in ‘mid-air’ with the next support level over two-points away, near 94.0.

Now, for the marked-up charts.

We’re using the ‘reverse’ trendline technique, presented in the Weis video to determine a potential right side trendline (black dashed line).

Next, we have the Up-Thrust on the daily which is also the right side of the ‘double top,’ shown on the weekly.

Taking both timeframes together, implies a significant inflection point (not advice, not a recommendation).

Anything can happen and the market could recover at the next session.

We’re below support (now resistance) and therefore, technically, in Wyckoff ‘spring’ position.

However, probabilities indicate we’ve had a downside pivot of some significance. That, along with heavy volume at Friday’s session would imply follow through at the next session (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Positioned For Trouble

August 3, 2024 By in $SPSIBI, Biotech, LABD, LABD-24-16, SOXS, SPBIO, Wyckoff, XBI, ZeroHedge 1 Comment

When The Tide Goes Out

We all know the quote attributed to Buffett:

‘When the tide goes out, that’s when you find out who’s been swimming naked’.

Or, to put it another way:

‘Everybody’s a genius in a bull market’.

Well, ladies and gentlemen, here we are.

We’re about to witness what method’s best suited to handle typical ‘price destruction’ behavior of a bear market (here and here) along with possible chaos in commodities.

That challenge also includes this site of course.

Bear Market Behavior

If we’re really entering a bear market, prices typically do not go straight down unless there’s an outright crash.

No …Bear markets are all about what’s called ‘price destruction’.

That is, price action whipsaws a near infinite number of times; getting into (a short) position for the downside or (long for) an upside squeeze is incredibly difficult.

The most recent example of this was the volatile whipsaws in 3X leveraged inverse fund, SOXS:

Swings over +/- 20%, back-to-back in days if not hours.

With that said, we’re looking at biotech XBI, to see if there’s a chance of it being ‘well-behaved’ during a decline (not advice, not a recommendation).

Biotech XBI, Weekly

On a weekly close basis, we’ve had a double top.

Using the MACD, it shows momentum weakened on the leg up to the second top.

Watching price action (the tape) of XBI late Friday, near the close, it gave the appearance of short covering.

Upward spikes that appeared to be labored.

If that’s true, then a lower open at the next session would be the expectation (not advice, not a recommendation).

Taking Action

As the disclaimer states, this site is ‘not certified’ by the SEC and does not, cannot provide any advice.

What it can do, is infer the actions being taken.

With that said, this update shows the ‘category’ side bar with LABD-24-16, thus inferring a short position via LABD.

That’s the firm’s identifier used for spreadsheet tracking; the 16th biotech short via LABD, for the year.

Never Too Early, To Trend

In the next update, we’ll discuss how even in the early stages of (potential) XBI reversal, we may already have a trendline.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

The ‘Squeeze’ That Didn’t

July 31, 2024 By in $SPSIBI, Biotech, LABD, LABD-24-16, SOXS, SOXX, SPBIO, XBI 2 Comments

Biotech Refused To Play

During today’s Fed induced squeeze, one index was noticeably stubborn.

Biotech looked like it was going to play along.

However, as the regular session wrapped-up, biotech XBI, retraced, proceeding all the way down to close near its prior day’s close.

Biotech XBI, Hourly

The hourly chart shows the initial squeeze that didn’t.

The last hour had significant volume, indicating the potential for more downside at the next session (not advice, not a recommendation).

Contrast performance of leveraged inverse semiconductors SOXS, at a massive -20.21%, loss on the day to leveraged inverse biotech LABD, at just -0.34%, loss for the day.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279